Surgical site infections (SSIs) affect 2–5% of all surgical patients, contributing to 1 million additional hospital days annually in the US alone at an excess cost of $10B. The global burden of antimicrobial resistance (AMR), projected to cause 10 million annual deaths by 2050, is significantly worsened by prophylactic and excessive topical antibiotic use. ChronoGraft is a smart wound dressing that continuously monitors the biochemical environment of a surgical wound and autonomously delivers a therapeutic antibiotic dose precisely when and only when infection indicators breach clinical thresholds, eliminating both late detection and antibiotic overuse in a single device.

How it works: ChronoGraft is a three-layer flexible dressing. The bottom contact layer is a biocompatible hydrogel matrix (polyvinyl alcohol cross-linked with hyaluronic acid) that maintains wound moisture and serves as the sensor-drug interface. Embedded within this layer are: (1) a pH sensor array, infection causes local acidosis as bacteria produce lactic acid, shifting wound pH from ~7.4 to below 6.5; (2) an electrochemical enzyme biosensor targeting matrix metalloproteinase-9 (MMP-9), a protease elevated 10× during active bacterial infection; and (3) colorimetric strips for visual clinical confirmation.

The middle layer contains 40 thermoresponsive drug microcapsules per cm², each loaded with ciprofloxacin-HCl and coated with poly(N-isopropylacrylamide), a polymer that swells and becomes permeable above 37.5°C. A 200 μm Joule heating wire mesh, powered by a coin cell and controlled by a microcontroller receiving the biosensor signals, selectively activates capsule zones when both pH and MMP-9 thresholds are simultaneously crossed, a dual-trigger requirement that prevents false positives.

The outer layer is a standard breathable polyurethane film. Total drug load is calibrated for a 72-hour post-surgical window, the highest-risk period. The dressing communicates wirelessly via NFC, no battery required for communication, powered from reader proximity, to nursing station scanners, logging biosensor values to the EHR.

What makes it novel: Existing smart dressings detect infection markers passively and alert clinicians, who then apply antibiotics manually, introducing delay. ChronoGraft is the first closed-loop dressing: it detects and treats autonomously within minutes of threshold breach, without nurse intervention. The dual-biomarker gating and thermoresponsive microcapsule release mechanism prevent antibiotic overuse that renders single-trigger systems clinically risky.

Manufacturing: Hydrogel matrix manufactured via UV photo-crosslinking; microcapsules produced by microfluidic droplet generation, both scalable batch processes. Sensor electrodes screen-printed on the gel using silver-carbon ink. Total material cost at scale: $7–$11 per dressing. Compatible with existing sterile wound dressing packaging and distribution chains.

Where it's applied: Post-surgical wound closure, chronic diabetic ulcers, burn wound management, trauma care in field or remote environments.

Market potential: Global advanced wound dressing market: $12B, growing at 6.2% CAGR. SSI prevention initiatives across hospital systems create strong institutional procurement demand. AMR-reduction mandates from WHO and CMS provide regulatory tailwinds for adoption.